NO924637D0 - Fremgangsmaate ved forhindring av gjentilstopping av arterier - Google Patents

Fremgangsmaate ved forhindring av gjentilstopping av arterier

Info

Publication number
NO924637D0
NO924637D0 NO924637A NO924637A NO924637D0 NO 924637 D0 NO924637 D0 NO 924637D0 NO 924637 A NO924637 A NO 924637A NO 924637 A NO924637 A NO 924637A NO 924637 D0 NO924637 D0 NO 924637D0
Authority
NO
Norway
Prior art keywords
arteries
procedure
repeating
preventing repeating
preventing
Prior art date
Application number
NO924637A
Other languages
English (en)
Other versions
NO303047B1 (no
NO924637L (no
Inventor
David Frederick Horrobin
John Charles Marshall Stewart
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of NO924637D0 publication Critical patent/NO924637D0/no
Publication of NO924637L publication Critical patent/NO924637L/no
Publication of NO303047B1 publication Critical patent/NO303047B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Control Of Turbines (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Amplifiers (AREA)
  • Glass Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Semiconductor Lasers (AREA)
  • Drying Of Semiconductors (AREA)
NO924637A 1991-12-02 1992-12-01 Anvendelse av <gamma>-linolensyre og/eller dihomo-<gamma>-linolensyre og eikosapentaensyre NO303047B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125602A GB9125602D0 (en) 1991-12-02 1991-12-02 Method of preventing reocclusion of arteries

Publications (3)

Publication Number Publication Date
NO924637D0 true NO924637D0 (no) 1992-12-01
NO924637L NO924637L (no) 1993-06-03
NO303047B1 NO303047B1 (no) 1998-05-25

Family

ID=10705559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924637A NO303047B1 (no) 1991-12-02 1992-12-01 Anvendelse av <gamma>-linolensyre og/eller dihomo-<gamma>-linolensyre og eikosapentaensyre

Country Status (17)

Country Link
US (2) US5378732A (no)
EP (2) EP0551729B1 (no)
JP (1) JPH05286854A (no)
KR (1) KR930012009A (no)
AT (1) ATE133334T1 (no)
AU (2) AU657009B2 (no)
CA (1) CA2084273A1 (no)
DE (1) DE69207885T2 (no)
DK (1) DK0551729T3 (no)
ES (1) ES2082390T3 (no)
GB (1) GB9125602D0 (no)
GR (1) GR3019270T3 (no)
HK (1) HK131096A (no)
NO (1) NO303047B1 (no)
NZ (1) NZ245343A (no)
TW (1) TW223589B (no)
ZA (1) ZA929316B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
MXPA06013990A (es) * 2004-04-30 2007-08-14 Virtus Nutrition Llc Sintesis de sal de metal monovalente y divalente de acido graso polinsaturado.
WO2008088030A1 (ja) * 2007-01-17 2008-07-24 Mochida Pharmaceutical Co., Ltd. 血栓もしくは塞栓に関連する疾患の予防又は治療用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1240513A (en) * 1968-09-13 1971-07-28 Ono Pharmaceutical Co Poly-unsaturated fatty acid ester composition and its preparation
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids

Also Published As

Publication number Publication date
GR3019270T3 (en) 1996-06-30
AU1656395A (en) 1995-06-29
DE69207885T2 (de) 1996-07-25
US5378732A (en) 1995-01-03
ZA929316B (en) 1993-09-09
KR930012009A (ko) 1993-07-20
EP0676197A3 (en) 1996-09-11
DE69207885D1 (de) 1996-03-07
HK131096A (en) 1996-07-26
GB9125602D0 (en) 1992-01-29
EP0551729B1 (en) 1996-01-24
CA2084273A1 (en) 1993-06-03
ATE133334T1 (de) 1996-02-15
NO303047B1 (no) 1998-05-25
EP0551729A1 (en) 1993-07-21
NZ245343A (en) 1997-06-24
TW223589B (no) 1994-05-11
JPH05286854A (ja) 1993-11-02
US5859055A (en) 1999-01-12
DK0551729T3 (da) 1996-02-12
AU2968792A (en) 1993-06-03
NO924637L (no) 1993-06-03
ES2082390T3 (es) 1996-03-16
AU680725B2 (en) 1997-08-07
AU657009B2 (en) 1995-02-23
EP0676197A2 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
ZA9425B (en) Compositions containing esters of unsaturated fatty acids
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
GR3025178T3 (en) Medicament for the treatment of vulvar dystrophy or vaginal dryness
GR3018185T3 (en) Medicaments containing polyhydroxymethylene-derivatives, process for their manufacture and use thereof.
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
AU633603B2 (en) Pharmaceutical compositions
DK0458287T3 (da) Anvendelse af magnesium-pyridoxal-5-phosphat-glutaminat til forebyggelse af sygdomme forårsaget af vaskulære læsioner
NO924637D0 (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
FR2669826B1 (fr) Catheter pour la dilatation des arteres.
IT212830Z2 (it) Giuoco da tavolo basato sull&#39;ominimia delle parole
ITBS920070V0 (it) Catetere per la disostruzione delle arterie